Home Cart Sign in  
Chemical Structure| 54029-12-8 Chemical Structure| 54029-12-8

Structure of Albendazole Sulfoxide
CAS No.: 54029-12-8

Chemical Structure| 54029-12-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Albendazole Oxide can selectively inhibit beta-tubulin polymerization, used as an anthelmintic medicine.

Synonyms: Ricobendazole; Albendazole Oxide; RS 8852

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Albendazole Sulfoxide

CAS No. :54029-12-8
Formula : C12H15N3O3S
M.W : 281.33
SMILES Code : O=C(OC)NC1=NC2=CC=C(S(CCC)=O)C=C2N1
Synonyms :
Ricobendazole; Albendazole Oxide; RS 8852
MDL No. :MFCD00797922
InChI Key :VXTGHWHFYNYFFV-UHFFFAOYSA-N
Pubchem ID :83969

Safety of Albendazole Sulfoxide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Albendazole Sulfoxide

cytoskeleton

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Echinococcus multilocularis metacestodes 10 μg/ml 1 hour to 16 days To evaluate the in vitro efficacy of albendazole sulfoxide and albendazole sulfone against E. multilocularis metacestodes. Results showed that both drugs were rapidly taken up by the parasite, causing structural changes in microtriches within 6 hours and ultimately leading to parasite death. Antimicrob Agents Chemother. 1999 May;43(5):1052-61
Echinococcus granulosus protoscoleces 50, 150, 250 µM 10 days Evaluate the in vitro protoscolicidal effects of albendazole sulfoxide on Echinococcus granulosus protoscoleces. Results showed that albendazole sulfoxide exhibited protoscolicidal effects at all concentrations but was less effective than tropisetron. Parasit Vectors. 2021 Apr 12;14(1):197
Trichuris muris 5-100 μM 24 h To assess the pathway of drug entry and drug accumulation in parasites. Results showed that Albendazole Sulfoxide accumulated in parasites between 61 and 833 nmol/10 worms, with a concentration-dependent manner. Int J Parasitol Drugs Drug Resist. 2017 Aug;7(2):159-173
Heligmosomoides polygyrus 5-100 μM 24 h To assess the pathway of drug entry and drug accumulation in parasites. Results showed that Albendazole Sulfoxide accumulated in parasites between 12 and 111 nmol/10 worms, with a concentration-dependent manner. Int J Parasitol Drugs Drug Resist. 2017 Aug;7(2):159-173
Taenia solium cysts 10 to 500 ng/ml 72 h To evaluate the antiparasitic activities of racemic ABZSO and its (R)- and (S)- enantiomers against T. solium cysts. Results showed that (R)-ABZSO was significantly more active than (S)-ABZSO in suppressing the release of AP and antigen in a dose- and time-dependent manner. Antimicrob Agents Chemother. 2013 Feb;57(2):944-9
Taenia crassiceps cysts 0.0125 to 2.5 μg/ml 11 days Evaluate the in vitro effects of albendazole sulfoxide against Taenia crassiceps cysts, showing it acts slower and is less potent than praziquantel. Antimicrob Agents Chemother. 2004 Jun;48(6):2302-4
African green monkey kidney cells (E6) 1 to 10 ng/ml 14 days Evaluate the inhibitory effect of albendazole sulfoxide on Encephalitozoon intestinalis spore production; results showed albendazole sulfoxide was 1.7-fold more inhibitory than albendazole and significantly less toxic to E6 cells Antimicrob Agents Chemother. 1997 Dec;41(12):2729-32
Human recombinant cytochrome P450 (CYP1A2) 14.9 µM(IC50) Evaluate the inhibitory effect of Albendazole Sulfoxide on CYP1A2, showing moderate inhibition (IC50=14.9µM) Antimicrob Agents Chemother. 2016 Sep 23;60(10):6127-33

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
NMRI mice Heligmosomoides polygyrus infection model Oral and intraperitoneal 100 mg/kg Single dose, sampling at 2, 5, and 8 hours post-treatment To evaluate the distribution of Albendazole Sulfoxide in the host and its effect on parasites. Results showed that after oral administration of Albendazole Sulfoxide, the drug accumulated in parasites at 11.4 nmol/10 worms, with high concentrations in gastrointestinal contents and plasma. Int J Parasitol Drugs Drug Resist. 2017 Aug;7(2):159-173
Rats Sprague-Dawley rats Oral 100 mg/kg Single dose, monitored for 24 hours Evaluate pharmacokinetic parameters of Albendazole Sulfoxide in rats, showing a 1.8-fold increase in half-life when coadministered with mebendazole compared to albendazole alone Antimicrob Agents Chemother. 2016 Sep 23;60(10):6127-33

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.55mL

0.71mL

0.36mL

17.77mL

3.55mL

1.78mL

35.55mL

7.11mL

3.55mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories